- Q1 2024 Organon & Co Earnings Call TranscriptMay 02, 2024MXN299Earnings
- Q4 2023 Organon & Co Earnings Call TranscriptFeb 15, 2024MXN270Earnings
- Organon & Co at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Organon & Co at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Q3 2023 Organon & Co Earnings Call TranscriptNov 02, 2023MXN281Earnings
- Q2 2023 Organon & Co Earnings Call TranscriptAug 08, 2023MXN360Earnings
- Q1 2023 Organon & Co Earnings Call TranscriptMay 04, 2023MXN425Earnings
- Q4 2022 Organon & Co Earnings Call TranscriptFeb 16, 2023MXN500 (-6.72%)Earnings
- Organon & Co at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Organon & Co at Piper Sandler Healthcare Conference TranscriptNov 29, 2022
- Q3 2022 Organon & Co Earnings Call TranscriptNov 03, 2022MXN500Earnings
- Q2 2022 Organon & Co Earnings Call TranscriptAug 04, 2022MXN647.72Earnings
- Q1 2022 Organon & Co Earnings Call TranscriptMay 05, 2022MXN663Earnings
- Organon & Co at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Q4 2021 Organon & Co Earnings Call TranscriptFeb 17, 2022MXN694.06Earnings
- Organon & Co at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Organon & Co at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Q3 2021 Organon & Co Earnings Call TranscriptNov 11, 2021MXN670 (-11.48%)Earnings
- Organon & Co at Morgan Stanley Global Healthcare Conference (Fireside Chat) TranscriptSep 13, 2021
- Q2 2021 Organon & Co Earnings Call TranscriptAug 12, 2021MXN668 (+11.52%)Earnings
Q4 2022 Organon & Co Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Organon Fourth Quarter and Full Year 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this call is being recorded. I would now like to turn the call over to Jennifer Halchak, Vice President, Investor Relations. Please begin your conference.
Thank you, Dennis. Good morning, everyone. Thank you for joining Organon's Fourth Quarter and Full Year 2022 Earnings Call. With me today are Kevin Ali, Organon's Chief Executive Officer, who will cover strategy and operational highlights; and Matt Walsh, our Chief Financial Officer, who will review performance, guidance and capital allocation. Dr. Sandra Milligan Organon's Head of R&D, will also be joining us for the Q&A portion of this call.
Today, we will be referencing a presentation that will be visible during this call for those of you on our webcast. This presentation will also be available following this call on the Events and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)